ATE278693T1 - Zyklische verbindungen welche nukleotidebasen- spezifische wechselwirkung mit doppelsträngiger nukleinsäure eingehen - Google Patents

Zyklische verbindungen welche nukleotidebasen- spezifische wechselwirkung mit doppelsträngiger nukleinsäure eingehen

Info

Publication number
ATE278693T1
ATE278693T1 AT00903143T AT00903143T ATE278693T1 AT E278693 T1 ATE278693 T1 AT E278693T1 AT 00903143 T AT00903143 T AT 00903143T AT 00903143 T AT00903143 T AT 00903143T AT E278693 T1 ATE278693 T1 AT E278693T1
Authority
AT
Austria
Prior art keywords
double
compounds
stranded nucleic
enter
nucleic acid
Prior art date
Application number
AT00903143T
Other languages
English (en)
Inventor
Eldon E Baird
Peter B Dervan
Original Assignee
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn filed Critical California Inst Of Techn
Application granted granted Critical
Publication of ATE278693T1 publication Critical patent/ATE278693T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
AT00903143T 1999-01-08 2000-01-06 Zyklische verbindungen welche nukleotidebasen- spezifische wechselwirkung mit doppelsträngiger nukleinsäure eingehen ATE278693T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11523299P 1999-01-08 1999-01-08
PCT/US2000/000298 WO2000040605A2 (en) 1999-01-08 2000-01-06 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids

Publications (1)

Publication Number Publication Date
ATE278693T1 true ATE278693T1 (de) 2004-10-15

Family

ID=22360079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903143T ATE278693T1 (de) 1999-01-08 2000-01-06 Zyklische verbindungen welche nukleotidebasen- spezifische wechselwirkung mit doppelsträngiger nukleinsäure eingehen

Country Status (7)

Country Link
EP (1) EP1144414B1 (de)
JP (1) JP2002539077A (de)
AT (1) ATE278693T1 (de)
AU (1) AU2493100A (de)
CA (1) CA2358119A1 (de)
DE (1) DE60014579T2 (de)
WO (1) WO2000040605A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528620B1 (en) 1999-11-08 2003-03-04 University Of Utah Research Foundation Sid-polyamide fusions: a potent method of regulating gene expression
US7078536B2 (en) 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
DE60128551D1 (de) 2000-03-16 2007-07-05 Genesoft Inc Geladene verbindungen mit einer nukleinsäure-bindenden einheit sowie deren verwendungen
US7498349B2 (en) 2002-08-02 2009-03-03 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
EP1562931A2 (de) 2002-10-25 2005-08-17 Genesoft Pharmaceuticals, Inc. Biarylverbindungen mitantiinfektionswirkung
EP1587529A4 (de) 2002-12-10 2009-08-12 Oscient Pharmaceuticals Corp Antibakterielle verbindungen mit(pyrrolcarboxamid)-(benzamid)-(imidazolcarboxamid)-motiv
EP1599474B1 (de) * 2003-03-04 2013-04-24 California Institute Of Technology Heterocyclische oligomere Verbindungen zur DNS-Erkennung
CN1845733A (zh) * 2003-09-04 2006-10-11 学校法人日本大学 TGF-β基因表达抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
JP2002515897A (ja) * 1996-02-26 2002-05-28 カリフォルニア・インスティチュート・オブ・テクノロジー 特異的ポリアミドdna−結合リガンドの設計、合成、および使用
CN1260006A (zh) * 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
WO1998037066A1 (en) * 1996-02-26 1998-08-27 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
EP1023288A1 (de) * 1996-02-26 2000-08-02 California Institute Of Technology Stereochemische kontrolle der dna-bindungsaffinität, sequenz-spezifität und orientierungspräferenz von chiralen hairinpolyamiden an den kleinen graben
JP2002515057A (ja) * 1996-08-01 2002-05-21 カリフォルニア・インスティチュート・オブ・テクノロジー ポリアミドdna結合リガンドによる遺伝子発現の阻害
CA2286232A1 (en) * 1997-04-06 1998-11-05 California Institute Of Technology Dna-binding pyrrole and imidazole polyamide derivatives

Also Published As

Publication number Publication date
JP2002539077A (ja) 2002-11-19
WO2000040605A9 (en) 2001-10-25
EP1144414B1 (de) 2004-10-06
EP1144414A2 (de) 2001-10-17
AU2493100A (en) 2000-07-24
WO2000040605A2 (en) 2000-07-13
CA2358119A1 (en) 2000-07-13
DE60014579T2 (de) 2006-03-09
WO2000040605A3 (en) 2000-11-30
DE60014579D1 (de) 2004-11-11

Similar Documents

Publication Publication Date Title
Saarbach et al. Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics
Li et al. Polymeric DNA hydrogel: Design, synthesis and applications
Zhang et al. Smart and functionalized development of nucleic acid‐based hydrogels: Assembly strategies, recent advances, and challenges
Sharma et al. Versatility of peptide nucleic acids (PNA s): Role in chemical biology, drug discovery, and origins of life
Nielsen Peptide nucleic acid. A molecule with two identities
Soontornworajit et al. Aptamer-functionalized in situ injectable hydrogel for controlled protein release
ATE394674T1 (de) Funktionalisierte nanopartikel und verwendungsverfahren
Riccardi et al. Fluorescent thrombin binding aptamer-tagged nanoparticles for an efficient and reversible control of thrombin activity
Hnedzko et al. Sequence-selective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids
Shi et al. Responsive DNA-based supramolecular hydrogels
Häner et al. Oligopyrenotides: abiotic, polyanionic oligomers with nucleic acid-like structural properties
CN106661577A (zh) 反义核酸
Chang et al. Strand selective cleavage of DNA by diastereomers of hairpin polyamide-seco-CBI conjugates
Appukutti et al. High definition polyphosphoesters: between nucleic acids and plastics
Holzhauser et al. DNA and RNA “traffic lights”: Synthetic wavelength-shifting fluorescent probes based on nucleic acid base substitutes for molecular imaging
Acevedo-Jake et al. AT-CuAAC synthesis of mechanically interlocked oligonucleotides
US20190119734A1 (en) Sensors for nucleic acid biomarkers
Moccia et al. Insights on chiral, backbone modified peptide nucleic acids: properties and biological activity
Prakash et al. 2 ‘-O-[2-(Guanidinium) ethyl]-modified oligonucleotides: stabilizing effect on duplex and triplex structures
ATE278693T1 (de) Zyklische verbindungen welche nukleotidebasen- spezifische wechselwirkung mit doppelsträngiger nukleinsäure eingehen
CY1106041T1 (el) Καινοφανης συλλεκτινη
de Rochambeau et al. Modular strategy to expand the chemical diversity of DNA and sequence-controlled polymers
Bhingardeve et al. Receptor-specific delivery of peptide nucleic acids conjugated to three sequentially linked N-acetyl galactosamine moieties into hepatocytes
Kashida et al. A cationic dye triplet as a unique “Glue” that can connect fully matched termini of DNA duplexes
Nordell et al. DNA polymorphism as an origin of adenine-thymine tract length-dependent threading intercalation rate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties